Dr. Philp McMillan, John McMillan
Science often proceeds from observation to hypothesis. In an era when medical data typically remains locked behind institutional walls, a group of 350 Japanese volunteers armed with determination and Freedom of Information requests compiled and analyzed 21 million vaccination records. This citizen-led initiative revealed something that standard safety monitoring missed: a concerning spike in deaths occurring not days or weeks, but three to four months after vaccination.
The project, spearheaded by the United Citizens for Stopping mRNA Vaccines and the Yukoku Alliance, represents citizen science on an unprecedented scale. These volunteers, working without government funding or pharmaceutical industry support, analyzed records from approximately 40 municipalities across Japan, painstakingly compiling vaccination dates, lot numbers, and mortality data from the country’s highly reliable resident registration systems. While the sample represents only a fraction of Japan’s 3,300 municipalities, the pattern they discovered demands attention.
A Pattern Emerges: The 90-Day Mortality Peak
At a July 2025 press conference streamed worldwide, Professor Yasufumi Murakami of the Tokyo University of Science shared the findings and highlighted a troubling trend: mortality among vaccinated individuals appeared to peak between 90 and 120 days after vaccination, while death rates in the unvaccinated group remained consistently lower and stable. Even more striking, each additional dose seemed to shorten the time to peak mortality, pointing to a possible cumulative effect.
The numbers are sobering. Professor Murakami estimates that between 600,000 and 610,000 excess deaths may have occurred in Japan in temporal association with the vaccination campaign. While the volunteer analysis cannot prove causation, such figures demand rigorous investigation.
“If the vaccination is not the real cause of this death, then there will be no this kind of significant peak,” Professor Murakami stated during the presentation.
A Blind Spot and a Biological Hypothesis
Dr. Philip McMillan, a clinician and researcher reviewing the findings independently, offered crucial perspective on why this timeline matters. He explained that it is difficult to correlate an injury to a vaccine when there is a long delay, noting that connections emerging three to four months later are often missed.
The data revealed another unsettling pattern: individuals who received more doses appeared to experience these mortality peaks sooner. Third-dose recipients showed earlier peaks than those who received only two doses, suggesting what researchers describe as a possible cumulative effect.
What makes these findings particularly significant is their potential to explain a puzzle that has troubled health officials worldwide: persistently elevated excess mortality rates in highly vaccinated populations, even after COVID-19 deaths declined. If deaths are occurring months after vaccination, traditional 28-day monitoring windows would completely miss them.
Dr. McMillan proposed a biological mechanism that could explain the delayed mortality peak. Rather than direct vaccine toxicity, he suggests an autoimmune process combined with increased susceptibility to reinfection could create what he terms a “COVID storm,” a blast of immune responses affecting multiple organs that occurs when vaccine-primed immune systems encounter the virus again.
“My feeling is that it’s a combination of immune responses that are unusual with reinfection,” McMillan noted. “Three to four months after vaccination is not a direct toxic effect. This is something else.”
The volunteer project, despite its impressive scope, has clear limitations. The data comes from a non-representative sample of municipalities, and volunteers rather than trained epidemiologists handled the compilation. Most critically, the presentation lacks detailed explanation of how the unvaccinated control group was selected and matched, a fundamental requirement for drawing reliable comparisons.
The analysis also examines all-cause mortality without access to specific causes of death. While this approach captures deaths that might otherwise be overlooked, it cannot establish whether vaccines played any role in individual cases. Different vaccine types were grouped together, potentially masking important variations between products.
Yet dismissing these findings entirely would be premature. The project has identified a specific timeframe that deserves professional investigation. The 90-to-120-day window represents a blind spot in current vaccine safety monitoring systems, which typically focus on immediate adverse events.
A Call for Rigorous Investigation
If confirmed, these findings would revolutionize vaccine safety monitoring, extending surveillance windows and changing how we assess long-term risks. If disproven through rigorous study, that too would provide valuable reassurance.
Professional researchers with access to comprehensive national health databases must now test whether this pattern holds in larger, more representative populations. Autopsy reports and detailed medical records could help identify potential biological mechanisms. Proper case-control studies matching vaccinated and unvaccinated individuals by age, health status, and other relevant factors could provide definitive answers.
The Japanese volunteers haven’t provided definitive proof of vaccine harm. That wasn’t their role. They’ve identified a pattern that professional scientists must now investigate. In an age when medical research often seems distant from ordinary citizens, this project demonstrates how concerned individuals can uncover important details that experts might have overlooked.
The global pharmaceutical industry is pressing ahead with plans for future vaccination campaigns, including planned mRNA flu shots. Japanese citizen scientists have countered this push with a compelling hypothesis. The volunteers have shown us where to look. Now it’s time for the scientific community to look carefully, transparently, and without prejudice at what might be found there.
0 Comments